tci Medicare Compliance & Reimbursement - 2004 Issue 30
Drug Payments: Doc Pay Rule Cuts Drugs Up To 89 Percent
Subscribe or sign in to view the full article.
Article Overview
This article reviews a proposed Medicare physician payment rule and its effect on reimbursement for physician-administered drugs under Medicare Part B. It is aimed at physicians, coders, billing staff, oncology and respiratory therapy practices, and anyone tracking CMS payment policy changes. The discussion covers the shift from older drug pricing methods to ASP-based payment, the role of administration fees, projected savings, and the broader impact on drug-related payments and practice revenue.
Why This Topic Matters
The rule could change how common physician-administered drugs are paid for, affecting practice reimbursement, beneficiary cost sharing, and planning for oncology and respiratory services.
What You Will Learn
- How the proposed Medicare physician payment rule affects physician-administered drug reimbursement
- Why CMS is changing the payment methodology for Medicare Part B drugs
- What categories of practices are expected to feel the largest payment impact
- How drug administration fees and related services factor into the overall payment picture
- Why coding updates for drug administration are relevant to the payment changes
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Practice managers
- Oncology practices
- Pulmonary/respiratory practices
- Healthcare compliance staff
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com